The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis

Molecular Therapy

Volumn 22, Issue 6, 2014, Pages 1122-1133

  Liang, Haihai ^a   Xu, Chaoqian ^a   Pan, Zhenwei ^a   Zhang, Ying ^a   Xu, Zhidan ^a   Chen, Yingzhun ^a   Li, Tianyu ^a   Li, Xuelian ^a   Liu, Ying ^a   Huangfu, Longtao ^a   Lu, Ying ^a   Zhang, Zhihua ^a   Yang, Baofeng ^a   Gitau, Samuel ^a   Lu, Yanjie ^a   Shan, Hongli ^a   Du, Zhimin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; MICRORNA 26A; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ANTAGOMIR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 2; MICRORNA; MIRN26 MICRORNA, MOUSE; MIRN26A MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXPERIMENTAL PULMONARY FIBROSIS; FIBROGENESIS; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL TISSUE; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; INTRACELLULAR SIGNALING; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TARGETING; UPREGULATION; ANIMAL; C57BL MOUSE; CELL LINE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION;

MUS;

ANIMALS; CELL LINE; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MICE; MICE, INBRED C57BL; MICRORNAS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84902154205     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.42     Document Type: Article

References (38)

1. Pandit, KV, Corcoran, D, Yousef, H, Yarlagadda, M, Tzouvelekis, A, Gibson, KF et al. (2010). Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 220-229.
2. Wynn, TA (2011). Integrating mechanisms of pulmonary fibrosis. J Exp Med 208: 1339-1350.
3. Verma, S and Slutsky, AS (2007). Idiopathic pulmonary fibrosis-new insights. N Engl J Med 356: 1370-1372.
4. Inui, M, Martello, G and Piccolo, S (2010). MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
5. Hu, X, Guo, J, Zheng, L, Li, C, Zheng, TM, Tanyi, JL et al. (2013). The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer. Mol Cancer Res 11: 240-250.
6. Braunwald, E (2013). Cardiovascular science: opportunities for translating research into improved care. J Clin Invest 123: 6-10.
7. Lu, Y, Zhang, Y, Wang, N, Pan, Z, Gao, X, Zhang, F et al. (2010). MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122: 2378-2387.
8. Liu, G, Friggeri, A, Yang, Y, Milosevic, J, Ding, Q, Thannickal, VJ et al. (2010). miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597.
9. Cushing, L, Kuang, PP, Qian, J, Shao, F, Wu, J, Little, F et al. (2011). miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45: 287-294.
10. Wei, C, Kim, I-K, Kumar, S, Jayasinghe, S, Hong, NY, Castoldi, G, et al. (2012). NF-kappaB mediated miR-26a regulation in cardiac fibrosis. J Cell Physiol 228: 1433-1442.
11. Luo, X, Pan, Z, Shan, H, Xiao, J, Sun, X, Wang, N, et al. (2013). MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest 123: 1939-1951.
12. Pan, Z, Sun, X, Shan, H, Wang, N, Wang, J, Ren, J et al. (2012). MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-1 pathway. Circulation 126: 840-850.
13. Daniels, A, van Bilsen, M, Goldschmeding, R, van der Vusse, GJ and van Nieuwenhoven, FA (2009). Connective tissue growth factor and cardiac fibrosis. Acta Physiol (Oxf) 195: 321-338.
14. Shan, H, Zhang, Y, Lu, Y, Zhang, Y, Pan, Z, Cai, B et al. (2009). Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 83: 465-472.
15. Wang, Z, Luo, X, Lu, Y and Yang, B (2008). miRNAs at the heart of the matter. J Mol Med (Berl) 86: 771-783.
16. Choi, WY, Giraldez, AJ and Schier, AF (2007). Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318: 271-274. (Pubitemid 47574854)
17. Li, D, Liu, X, Lin, L, Hou, J, Li, N, Wang, C et al. (2011). MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 286: 36677-36685.
18. Hou, J, Lin, L, Zhou, W, Wang, Z, Ding, G, Dong, Q et al. (2011). Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243.
19. Moore, BB and Hogaboam, CM (2008). Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L152-L160. (Pubitemid 351253350)
20. Vittal, R, Horowitz, JC, Moore, BB, Zhang, H, Martinez, FJ, Toews, GB et al. (2005). Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. Am J Pathol 166: 367-375. (Pubitemid 40189035)
21. He, W, Dorn, DC, Erdjument-Bromage, H, Tempst, P, Moore, MA and Massagué, J (2006). Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125: 929-941. (Pubitemid 43795187)
22. Yang, S, Xie, N, Cui, H, Banerjee, S, Abraham, E, Thannickal, VJ et al. (2012). miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis. FASEB J 26: 3790-3799.
23. Xiao, J, Meng, XM, Huang, XR, Chung, AC, Feng, YL, Hui, DS et al. (2012). miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther 20: 1251-1260.
24. Yang, S, Banerjee, S, de Freitas, A, Sanders, YY, Ding, Q, Matalon, S et al. (2012). Participation of miR-200 in pulmonary fibrosis. Am J Pathol 180: 484-493.
25. Suh, JH, Choi, E, Cha, MJ, Song, BW, Ham, O, Lee, SY et al. (2012). Upregulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3protein expression. Biochem Biophys Res Commun 423: 404-410.
26. Harada, M, Luo, X, Qi, XY, Tadevosyan, A, Maguy, A, Ordog, B et al. (2012). Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 126: 2051-2064.
27. Fernandez, IE and Eickelberg, O (2012). New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet 380: 680-688.
28. Kalluri, R and Weinberg, RA (2009). The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
29. Hinz, B, Phan, SH, Thannickal, VJ, Galli, A, Bochaton-Piallat, ML and Gabbiani, G (2007). The myofibroblast: one function, multiple origins. Am J Pathol 170: 1807-1816. (Pubitemid 47339255)
30. Tomasek, JJ, Gabbiani, G, Hinz, B, Chaponnier, C and Brown, RA (2002). Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363. (Pubitemid 34619269)
31. Lee, CG, Cho, S, Homer, RJ and Elias, JA (2006). Genetic control of transforming growth factor-beta1-induced emphysema and fibrosis in the murine lung. Proc Am Thorac Soc 3: 476-477. (Pubitemid 44285521)
32. Cutroneo, KR, White, SL, Phan, SH and Ehrlich, HP (2007). Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol 211: 585-589. (Pubitemid 46683026)
33. Blobe, GC, Schiemann, WP and Lodish, HF (2000). Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358. (Pubitemid 30408720)
34. Faherty, N, Curran, SP, O'Donovan, H, Martin, F, Godson, C, Brazil, DP et al. (2012). CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGF type II receptor with implications for nephropathic cell phenotypes. J Cell Sci 125(Pt 23): 5621-5629.
35. Davis, BN, Hilyard, AC, Lagna, G and Hata, A (2008). SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61. (Pubitemid 351931982)
36. Liang, H, Zhang, C, Ban, T, Liu, Y, Mei, L, Piao, X et al. (2012). A novel reciprocal loop between microRNA-21 and TGF RIII is involved in cardiac fibrosis. Int J Biochem Cell Biol 44: 2152-2160.
37. Williams, AH, Liu, N, van Rooij, E and Olson, EN (2009). MicroRNA control of muscle development and disease. Curr Opin Cell Biol 21: 461-469.
38. Yang, B, Lin, H, Xiao, J, Lu, Y, Luo, X, Li, B, et al. (2007). The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491. (Pubitemid 46559834)